Kolon TissueGene (950160) is continuing its strong performance, recording double-digit gains in early trading. Following an 11.40% surge on July 31, the stock has shown consecutive strength, recovering the 14,000-won level once again.

As of 9:41 a.m. on the 3rd, Kolon TissueGene is trading at 14,320 won, up 1,320 won (10.15%) from the previous trading day. At the same time, the domestic stock market showed mixed movements. The KOSPI fell by 298.95 points (4.53%) to 6,296.50 compared to the previous trading day, while the KOSDAQ rose by 8.29 points (1.15%) to 728.05, continuing its upward trend.

Kolon TissueGene is posting double-digit gains for the second consecutive day, following the previous trading day, demonstrating a consecutive surge. The stock price has once again recovered the 14,000-won level, attracting investor attention.

However, until recently, Kolon TissueGene had experienced a sharp decline over a short period, exhibiting high volatility. Although a rebound has been continuing recently, some opinions suggest that rather than concluding a trend reversal based solely on short-term price movements, a cautious approach is needed that also takes into account trading volume, supply and demand dynamics, and overall market sentiment.

Market attention is focused on whether Kolon TissueGene will continue its consecutive surge or whether profit-taking sell-offs will emerge following the short-term rally.

[※ This article is not intended to solicit investment, and investment decisions and responsibilities lie solely with the investor.]